FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.

# FDA Approves Hospira's Lidocaine Hydrochloride and Epinephrine Combination Injection Hospira, Inc. received FDA approval for its lidocaine hydrochloride and epinephrine infiltration injection, expanding the company's portfolio in the local anesthetic market and enabling it to compete in the established injectable anesthetic segment used widely across surgical and dental procedures. The approval positions Hospira to capture market share in a mature therapeutic category where combination local anesthetics represent a significant portion of procedural anesthetic usage in hospitals and surgical centers.